Q1 2025 · 13F-HR
Artia Global Partners LPholdings as filed
Filed 2025-05-15 · accession 0001937964-25-000004
$395.1M
Reported value
35
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 532457108 | LLY | ELI LILLY & CO | $78.4M | 19.8% | 94,887 | Common | SOLE |
| 532457108 | LLY | ELI LILLY & CO | $37.2M | 9.41% | 45,000 | PUT | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $35.6M | 9.01% | 498,473 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $34.2M | 8.65% | 538,488 | Common | SOLE |
| 46116X101 | ITCIEUR | INTRA-CELLULAR THERAPIES INC | $29.0M | 7.34% | 219,719 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $24.3M | 6.14% | 318,239 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $17.9M | 4.52% | 424,640 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $16.1M | 4.09% | 333,851 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $15.0M | 3.80% | 229,085 | Common | SOLE |
| 046353108 | AZNN | ASTRAZENECA PLC | $14.0M | 3.55% | 190,752 | Common | SOLE |
| 101137107 | BSX | BOSTON SCIENTIFIC CORP | $13.1M | 3.31% | 129,700 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $9.8M | 2.48% | 136,900 | PUT | SOLE |
| 74834L100 | DGX | QUEST DIAGNOSTICS INC | $9.6M | 2.43% | 56,717 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $7.7M | 1.95% | 28,600 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $7.1M | 1.81% | 100,000 | CALL | SOLE |
| 04016X101 | ARGX | ARGENX SE | $6.7M | 1.69% | 11,311 | Common | SOLE |
| 670703107 | NUVL | NUVALENT INC | $6.4M | 1.63% | 90,745 | Common | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $5.5M | 1.40% | 172,185 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $3.7M | 0.93% | 104,190 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $2.6M | 0.67% | 50,000 | Common | SOLE |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $2.4M | 0.60% | 53,930 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $2.2M | 0.55% | 90,279 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $2.2M | 0.55% | 160,000 | Common | SOLE |
| 88322Q108 | TGTX | TG THERAPEUTICS INC | $2.1M | 0.54% | 54,515 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $1.7M | 0.44% | 3,500 | Common | SOLE |
| 30233G209 | EYPT | EYEPOINT PHARMACEUTICALS INC | $1.7M | 0.43% | 316,700 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $1.6M | 0.41% | 14,700 | Common | SOLE |
| 91307C102 | UTHR | UNITED THERAPEUTICS CORP DEL | $1.5M | 0.39% | 5,000 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $1.3M | 0.34% | 40,000 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $1.2M | 0.29% | 7,440 | Common | SOLE |
| 47103J105 | JANX | JANUX THERAPEUTICS INC | $1.0M | 0.26% | 38,100 | Common | SOLE |
| 589492107 | MREO | MEREO BIOPHARMA GROUP PLC | $948,058 | 0.24% | 421,359 | Common | SOLE |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $553,728 | 0.14% | 30,900 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $506,550 | 0.13% | 35,226 | Common | SOLE |
| 687604108 | ORKA | ORUKA THERAPEUTICS INC | $75,719 | 0.02% | 7,380 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.